| Literature DB >> 35602164 |
Ang Li1, Wenjing Liao1, Junyang Xie1, Lijuan Song1, Xiaowen Zhang1,2.
Abstract
Harsh work environments can include very cold, hot, dusty, and noisy workplaces, as well as exposure in the workplace with chemicals and other fumes, cigarette smoke, and diesel exhaust. Although working in these harsh environments can have a negative effect on health, there are no effective biomarkers for monitoring health conditions until workers develop disease symptoms. Plasma protein concentrations, which reflect metabolism and immune status, have great potential as biomarkers for various health conditions. Using a Mendelian-randomization (MR) design, this study analyzed the effects of these harsh environments on plasma proteins to identify proteins that can be used as biomarkers of health status. Preliminary analysis using inverse variance weighted (IVW) method with a p-value cutoff of 0.05 showed that workplace environments could affect the concentrations of hundreds of plasma proteins. After filtering for sensitivity via MR-Egger, and Weighted Median MR approaches, 28 plasma proteins altered by workplace environments were identified. Further MR analysis showed that 20 of these plasma proteins, including UNC5D, IGFBP1, SCG3, ST3GAL6, and ST3GAL2 are affected by noisy workplace environments; TFF1, RBM39, ACYP2, STAT3, GRB2, CXCL1, EIF1AD, CSNK1G2, and CRKL that are affected by chemical fumes; ADCYAP1, NRSN1, TMEM132A, and CA10 that are affected by passive smoking; LILRB2, and TENM4 that are affected by diesel exhaust, are associated with the risk of at least one disease. These proteins have the potential to serve as biomarkers to monitor the occupational hazards risk of workers working in corresponding environments. These findings also provide clues to study the biological mechanisms of occupational hazards.Entities:
Keywords: Mendelian randomization; biomarker; occupational hazards; plasma protein; workplace environment
Mesh:
Substances:
Year: 2022 PMID: 35602164 PMCID: PMC9120921 DOI: 10.3389/fpubh.2022.852572
Source DB: PubMed Journal: Front Public Health ISSN: 2296-2565
Figure 1Framework of the study design. Preliminary Mendelian randomization (MR) analysis was performed using Genome Wide Association Study (GWAS) summary data of seven types of harmful working environments as exposures and GWAS summary data of 2,992 plasma proteins as outcomes. The robustness of the MR analysis was subsequently increased using MR-Egger and Weighted Median methods. The GWAS summary data for the selected plasma proteins are then used as exposures to evaluate the relationships between the plasma concentrations of these proteins and the risks of 28 diseases. Plasma proteins associated with the risk of at least one disease were selected as biomarkers to monitor corresponding occupational hazards.
Figure 2Preliminary screening of plasma proteins possibly affected by workplace environments. Mendelian randomization (MR) results with p < 0.05 were counted, with the Upset Plot showing outcomes overlapping among exposures to different environments.
Results of Mendelian randomization (MR) analysis of the associations between workplace environments and plasma protein levels using three MR methods.
|
|
|
|
|
| |||
|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
| |
|
| |||||||
| IGFBP1 | 18 | −0.309 (0.102) | 0.002 | −0.73 (0.286) | 0.021 | −0.429 (0.139) | 0.002 |
| SCG3 | 18 | −0.285 (0.128) | 0.026 | −0.92 (0.328) | 0.013 | −0.307 (0.156) | 0.048 |
| ST3GAL2 | 18 | 0.229 (0.108) | 0.034 | 0.806 (0.286) | 0.012 | 0.338 (0.144) | 0.019 |
| ST3GAL6 | 18 | −0.329 (0.102) | 0.001 | −0.805 (0.286) | 0.012 | −0.328 (0.142) | 0.021 |
| UNC5D | 18 | −0.316 (0.125) | 0.011 | −0.751 (0.341) | 0.043 | −0.342 (0.147) | 0.020 |
|
| |||||||
| COL1A1 | 13 | −0.277 (0.095) | 0.003 | −0.532 (0.21) | 0.028 | −0.364 (0.132) | 0.006 |
|
| |||||||
| GJA8 | 15 | 0.198 (0.089) | 0.026 | 0.527 (0.22) | 0.032 | 0.228 (0.114) | 0.045 |
|
| |||||||
| ACYP2 | 20 | 0.178 (0.065) | 0.006 | 0.45 (0.127) | 0.002 | 0.186 (0.085) | 0.029 |
| CRKL | 20 | 0.134 (0.061) | 0.028 | 0.272 (0.127) | 0.046 | 0.186 (0.08) | 0.019 |
| CSNK1G2 | 20 | 0.138 (0.061) | 0.023 | 0.284 (0.127) | 0.038 | 0.179 (0.082) | 0.028 |
| CXCL1 | 20 | 0.148 (0.073) | 0.042 | 0.43 (0.137) | 0.006 | 0.171 (0.082) | 0.038 |
| EFNA3 | 20 | −0.159 (0.066) | 0.017 | −0.311 (0.136) | 0.035 | −0.165 (0.081) | 0.042 |
| EIF1AD | 20 | 0.179 (0.07) | 0.010 | 0.363 (0.141) | 0.019 | 0.187 (0.085) | 0.028 |
| FAM107B | 20 | 0.217 (0.061) | 0.000 | 0.428 (0.127) | 0.003 | 0.201 (0.084) | 0.017 |
| FYN | 20 | 0.192 (0.062) | 0.002 | 0.505 (0.127) | 0.001 | 0.168 (0.085) | 0.048 |
| GRB2 | 20 | 0.151 (0.061) | 0.013 | 0.284 (0.127) | 0.038 | 0.189 (0.086) | 0.028 |
| HS3ST3A1 | 20 | 0.166 (0.061) | 0.006 | 0.275 (0.127) | 0.043 | 0.178 (0.086) | 0.039 |
| PAPSS1 | 20 | 0.121 (0.061) | 0.046 | 0.325 (0.127) | 0.019 | 0.169 (0.084) | 0.043 |
| RBM39 | 20 | 0.209 (0.061) | 0.001 | 0.407 (0.127) | 0.005 | 0.224 (0.081) | 0.006 |
| RPSA | 20 | 0.18 (0.061) | 0.003 | 0.294 (0.127) | 0.032 | 0.18 (0.083) | 0.031 |
| STAT3 | 20 | 0.168 (0.061) | 0.006 | 0.311 (0.127) | 0.024 | 0.161 (0.082) | 0.049 |
| TFF1 | 20 | −0.148 (0.068) | 0.029 | −0.468 (0.127) | 0.002 | −0.222 (0.085) | 0.009 |
|
| |||||||
| ADCYAP1 | 18 | −0.275 (0.096) | 0.004 | −0.534 (0.23) | 0.034 | −0.284 (0.132) | 0.031 |
| CA10 | 18 | 0.417 (0.106) | 0.000 | 0.604 (0.255) | 0.031 | 0.546 (0.142) | 0.000 |
| NRSN1 | 18 | −0.26 (0.112) | 0.020 | −0.56 (0.262) | 0.048 | −0.299 (0.132) | 0.023 |
| TMEM132A | 18 | 0.252 (0.096) | 0.009 | 0.552 (0.229) | 0.029 | 0.291 (0.133) | 0.029 |
|
| |||||||
| LILRB2 | 22 | −0.145 (0.044) | 0.001 | −0.237 (0.091) | 0.017 | −0.165 (0.06) | 0.006 |
| TENM4 | 22 | 0.143 (0.044) | 0.001 | 0.221 (0.091) | 0.025 | 0.159 (0.058) | 0.006 |
Figure 3Forest plot of Mendelian randomization (MR) results of the relationships between plasma proteins and selected diseases. Shown are the odds ratios (ORs), 95% confidence intervals (CIs) and p-values of MR analysis performed using the inverse variance weighted (IVW) method.